Portfolio · Haus

The companies
we backed first.

First checks into founders building inside the Haus network — equity owned from the earliest day.
Portfolio
The companies we backed first.
Haus writes the first check — before the priced round, before the crowd. These are companies built inside the network, where we own equity from the earliest day.
Origenity
AI-driven cell design — programming novel, functionally-optimised cell states beyond what exists in nature.
ToolsInvested
Wasna
Donor-free plasma and platelets — bringing the cost of a litre down by orders of magnitude.
Industrial BioInvestedRevenue
Nutr1l1nk
Bio-AI precision nutrients — designed compounds moving from the lab toward licensed products.
Industrial BioInvestedRevenue
Emerging in the network
Next off the bench.
Companies moving through the houses and labs — in diligence or early formation, not yet a priced investment.
Hypervariant
An immune-system aging clock — proteomics and AI for biological age.
Tools
Auctum Technologies
A ‘sliver’ human micro-organ for preclinical toxicology — riding the FDA’s animal-testing phase-out.
Tools
Broadcast Bio
Reads cellular ‘cellspeak’ (extracellular vesicles) to flag clinical-trial signals earlier.
Tools
Founders
Be the next
first check.
Building something in biology? We reach founders before anyone else does. Apply to a house and start here.
Apply → Get in touch